These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32305468)

  • 21. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P; Quinto L; Garre P; Zaraket F; Alarcón F; Borràs R; Caixal G; Vázquez S; Prat S; Ortiz-Perez JT; Perea RJ; Guasch E; Tolosana JM; Berruezo A; Arbelo E; Sitges M; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Aug; 18(8):1336-1343. PubMed ID: 33892202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry.
    Pontone G; Guaricci AI; Fusini L; Baggiano A; Guglielmo M; Muscogiuri G; Volpe A; Abete R; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Martini C; Marzo F; Masi A; Memeo R; Moro C; Nese A; Palumbo A; Pavon AG; Pedrotti P; Marra MP; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Masci PG; Schwitter J
    JACC Cardiovasc Imaging; 2023 Nov; 16(11):1387-1400. PubMed ID: 37227329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator.
    Urzua Fresno CM; Folador L; Shalmon T; Hamad FMD; Singh SM; Karur GR; Tan NS; Mangat I; Kirpalani A; Chacko BR; Jimenez-Juan L; Yan AT; Deva DP
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):72. PubMed ID: 34108003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
    Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
    Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators.
    Tan NS; Deva DP; Connelly KA; Angaran P; Mangat I; Jimenez-Juan L; Ng MY; Ahmad K; Kotha VK; Lima JAC; Crean AM; Dorian P; Yan AT
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):115. PubMed ID: 34670574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
    Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
    van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP
    J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator.
    Noordman ABP; Maass AH; Groenveld H; Mulder BA; Rienstra M; Blaauw Y
    Front Cardiovasc Med; 2021; 8():708406. PubMed ID: 34485409
    [No Abstract]   [Full Text] [Related]  

  • 30. Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients.
    Androulakis AFA; Zeppenfeld K; Paiman EHM; Piers SRD; Wijnmaalen AP; Siebelink HJ; Sramko M; Lamb HJ; van der Geest RJ; de Riva M; Tao Q
    JACC Clin Electrophysiol; 2019 Apr; 5(4):480-489. PubMed ID: 31000102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic denervation is associated with microvascular dysfunction in non-infarcted myocardium in patients with cardiomyopathy.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Wu L; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):788-98. PubMed ID: 25711350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J; Porter B; Claridge S; Chen Z; Sieniewicz BJ; Sidhu BS; Niederer S; Bishop MJ; Murgatroyd F; Ganeshan B; Carr-White G; Razavi R; Chiribiri A; Rinaldi CA
    Heart Rhythm; 2019 Aug; 16(8):1242-1250. PubMed ID: 30849532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
    Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate Spatial Complexity Analysis for the Prediction of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
    Okada DR; Miller J; Chrispin J; Prakosa A; Trayanova N; Jones S; Maggioni M; Wu KC
    Circ Arrhythm Electrophysiol; 2020 Apr; 13(4):e007975. PubMed ID: 32188287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial scarring and recurrence of ventricular arrhythmia in patients surviving an out-of-hospital cardiac arrest.
    Thomsen AF; Winkel BG; Golvano LCC; Porta-Sánchez A; Jøns C; Ferro E; Bertelsen L; Vazquez S; Bhardwaj P; Stampe NK; Ortiz-Perez JT; Andrea R; Engstrøm T; Køber L; Vejlstrup N; Mont L; Roca-Luque I; Jacobsen PK
    J Cardiovasc Electrophysiol; 2023 Nov; 34(11):2286-2295. PubMed ID: 37681321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
    J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Scott PA; Morgan JM; Carroll N; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):324-30. PubMed ID: 21493964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.